See also this year's filing and all EDGAR filings for this company.
PDF Report 0000855654_2013_Immunogen_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0000855654, Immunogen Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 166,270,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 11,633,000 |
| 3 | remainder_Assets | 2,405,000 |
| 4 | LiabilitiesCurrent | 16,254,000 |
| 5 | LiabilitiesNoncurrent | 3,798,000 |
| 6 | remainder_Liabilities | 76,366,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 20,422,000 |
| 9 | ResearchAndDevelopmentExpense | 69,192,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 16,357,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -62,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 180,308,000 |
| 1 | Liabilities | 96,418,000 |
| 2 | Expenses | 89,614,000 |
| 3 | Revenues | 16,357,000 |
| 4 | StockholdersEquity | 83,890,000 |
| 5 | NetIncome | -73,257,000 |
| 6 | ComprehensiveNetIncome | -73,288,000 |
| 7 | BaseVar | 191,379,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.792 |
| 9 | EconomicCapitalRatio | 2.13 |
Edgar->Model Mapping
Feature Distribution
Change over Time
